Naser Hadavand

971 total citations
13 papers, 111 citations indexed

About

Naser Hadavand is a scholar working on Geriatrics and Gerontology, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Naser Hadavand has authored 13 papers receiving a total of 111 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Geriatrics and Gerontology, 2 papers in Pharmacology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Naser Hadavand's work include Pharmaceutical Practices and Patient Outcomes (4 papers), Sepsis Diagnosis and Treatment (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Naser Hadavand is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (4 papers), Sepsis Diagnosis and Treatment (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Naser Hadavand collaborates with scholars based in Iran. Naser Hadavand's co-authors include Mohammadreza Javadi, Kheirollah Gholami, Hassan Torkamandi, Amir Sarayani, Pooneh Salari, Atabak Najafi, Molouk Hadjibabaie, Mohammad Reza Khajavi, Seyed Homayoon Sadraie and Zahra Jahangard‐Rafsanjani and has published in prestigious journals such as SHILAP Revista de lepidopterología, Pacing and Clinical Electrophysiology and Journal of Continuing Education in the Health Professions.

In The Last Decade

Naser Hadavand

13 papers receiving 99 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naser Hadavand Iran 5 44 20 17 17 14 13 111
André Bonnici Canada 6 65 1.5× 25 1.3× 10 0.6× 17 1.0× 9 0.6× 16 198
Luciane Kopittke Brazil 6 24 0.5× 11 0.6× 28 1.6× 16 0.9× 5 0.4× 19 133
Khaled Mohammed Alakhali Saudi Arabia 7 44 1.0× 14 0.7× 17 1.0× 11 0.6× 18 1.3× 25 142
Christiane Verny France 10 59 1.3× 12 0.6× 19 1.1× 15 0.9× 7 0.5× 23 252
K. Mulpeter Ireland 5 49 1.1× 8 0.4× 23 1.4× 18 1.1× 9 0.6× 6 146
Mesay Dechasa Ethiopia 5 34 0.8× 9 0.5× 8 0.5× 19 1.1× 5 0.4× 12 84
Jennifer Servais Canada 2 27 0.6× 11 0.6× 11 0.6× 15 0.9× 4 0.3× 2 93
Albert Trinh-Duc France 7 36 0.8× 5 0.3× 10 0.6× 25 1.5× 34 2.4× 13 108
Laia Matas Spain 6 61 1.4× 15 0.8× 6 0.4× 24 1.4× 32 2.3× 19 185
Pierre Renaudin France 6 100 2.3× 37 1.9× 17 1.0× 28 1.6× 7 0.5× 11 145

Countries citing papers authored by Naser Hadavand

Since Specialization
Citations

This map shows the geographic impact of Naser Hadavand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naser Hadavand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naser Hadavand more than expected).

Fields of papers citing papers by Naser Hadavand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naser Hadavand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naser Hadavand. The network helps show where Naser Hadavand may publish in the future.

Co-authorship network of co-authors of Naser Hadavand

This figure shows the co-authorship network connecting the top 25 collaborators of Naser Hadavand. A scholar is included among the top collaborators of Naser Hadavand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naser Hadavand. Naser Hadavand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Aghakouchakzadeh, Maryam, Kaveh Hosseini, Majid Haghjoo, et al.. (2024). Empagliflozin to prevent post‐operative atrial fibrillation in patients undergoing coronary artery bypass graft surgery. Pacing and Clinical Electrophysiology. 47(8). 1087–1095. 3 indexed citations
2.
3.
4.
Javadi, Mohammadreza, et al.. (2016). Role of pharmacist counseling in pharmacotherapy quality improvement. Journal of Research in Pharmacy Practice. 5(2). 132–132. 57 indexed citations
5.
Hadavand, Naser, et al.. (2016). Albumin Utilization Review to Evaluate The Efficacy and Cost, Perform as a Qualitative Study in Special Wards in Shaheed Rajaei Cardiovascular, Medical &Research Center. Biosciences Biotechnology Research Asia. 13(3). 1469–1477. 3 indexed citations
6.
Hadavand, Naser, et al.. (2016). Carbapenems, Linezolid, Teicoplanin Utilization Evaluation in a Large Teaching Based Hospital (Shahid Rajaie Heart Center, Tehran): A Quality Improvement Study. Biomedical & Pharmacology Journal. 9(2). 525–532. 1 indexed citations
7.
Hadavand, Naser, Alireza Hayatshahi, Hassan Torkamandi, et al.. (2015). Albumin Utilization in a Teaching Hospital in Tehran: Time to Revise the Prescribing Strategies. SHILAP Revista de lepidopterología. 6 indexed citations
8.
Sarayani, Amir, et al.. (2015). A 3-Armed Randomized Controlled Trial of Nurses’ Continuing Education Meetings on Adverse Drug Reactions. Journal of Continuing Education in the Health Professions. 35(2). 123–130. 12 indexed citations
9.
Hadavand, Naser, et al.. (2011). Current regulatory and scientific considerations for approving biosimilars in Iran. Biologicals. 39(5). 325–327. 8 indexed citations
10.
Salari, Pooneh, et al.. (2005). Comparison of the effect of aminophylline and low PEEP vs. high PEEP on EGF concentration in critically ill patients with ALI/ARDS. Journal of Clinical Pharmacy and Therapeutics. 30(2). 139–144. 11 indexed citations
11.
Hadavand, Naser, et al.. (2004). Pharmacokinetic Behavior of Theophylline following PEEP in Critically Ill Patients with Acute Lung Injury. Iranian journal of pharmaceutical research. 3(1). 35–40. 4 indexed citations
12.
Najafi, Atabak, et al.. (2003). THE EFFECT OF POSITIVE END EXPIRATORY PRESSURE ON PHARMACOKINETIC BEHAVIOR OF AMINOPHYLLINE IN PATIENTS WITH ACUTE LUNG INJURY. 23(42). 26–34. 1 indexed citations
13.
Mojtahedzadeh, Mojtaba, et al.. (2002). Pharmacokinetic behavior of Amikacin in 31 Iranian critically ill septic patients. DARU Journal of Pharmaceutical Sciences. 10(3). 111–119. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by André Bonnici Breakdown of academic impact, for papers by Luciane Kopittke Breakdown of academic impact, for papers by Khaled Mohammed Alakhali Breakdown of academic impact, for papers by Christiane Verny Breakdown of academic impact, for papers by K. Mulpeter Breakdown of academic impact, for papers by Mesay Dechasa Breakdown of academic impact, for papers by Jennifer Servais Breakdown of academic impact, for papers by Albert Trinh-Duc Breakdown of academic impact, for papers by Laia Matas Breakdown of academic impact, for papers by Pierre Renaudin
Rankless by CCL
2026